Concerns about consensus guidelines for QTc interval screening in methadone treatment [1]

Annals of Internal Medicine

Volumn 151, Issue 3, 2009, Pages 216-

  Byrne, Andrew ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; INSULIN; METHADONE; OPIATE;

CONSENSUS; DIABETES MELLITUS; DRUG MEGADOSE; DRUG SAFETY; DRUG SCREENING; ELECTROCARDIOGRAPHY; ELECTROLYTE DISTURBANCE; HEART ARRHYTHMIA; HUMAN; LETTER; MAINTENANCE THERAPY; METHADONE TREATMENT; MORTALITY; OPIATE ADDICTION; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QT INTERVAL; TACHYCARDIA; TORSADE DES POINTES; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 68249108643     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-151-3-200908040-00013     Document Type: Letter

References (3)

1. Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC. QTc interval screening in methadone treatment. Ann Intern Med. 2009;150:387-95. [PMID: 19153406]
2. Kakko J, Grönbladh L, Svanborg KD, von Wachenfeldt J, Rück C, Rawlings B, et al. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. Am J Psychiatry. 2007;164:797-803. [PMID: 17475739]
3. Justo D, Gal-Oz A, Paran Y, Goldin Y, Zeltser D. Methadone-associated torsades de pointes (polymorphic ventricular tachycardia) in opioid-dependent patients. Addiction. 2006;101:1333-8. [PMID: 16911733]